 Richard Duke
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Glycoproteins | 17 | 2004 | 443 | 0.980 |
Why?
| | Apoptosis | 21 | 2012 | 2461 | 0.860 |
Why?
| | Fas Ligand Protein | 16 | 2012 | 60 | 0.780 |
Why?
| | T-Lymphocytes, Cytotoxic | 9 | 2006 | 159 | 0.750 |
Why?
| | Cytotoxicity, Immunologic | 11 | 2004 | 197 | 0.510 |
Why?
| | Genetic Therapy | 4 | 2012 | 267 | 0.460 |
Why?
| | Killer Cells, Natural | 3 | 2004 | 380 | 0.400 |
Why?
| | fas Receptor | 8 | 2004 | 98 | 0.380 |
Why?
| | Bone Neoplasms | 1 | 2012 | 198 | 0.360 |
Why?
| | Immunotherapy | 5 | 2010 | 493 | 0.340 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2006 | 130 | 0.340 |
Why?
| | Chromatin | 3 | 2004 | 439 | 0.330 |
Why?
| | T-Lymphocytes | 11 | 2004 | 1771 | 0.300 |
Why?
| | Viral Hepatitis Vaccines | 1 | 2006 | 1 | 0.300 |
Why?
| | Viral Core Proteins | 1 | 2006 | 21 | 0.290 |
Why?
| | Saccharomyces cerevisiae | 4 | 2010 | 494 | 0.280 |
Why?
| | Viral Nonstructural Proteins | 1 | 2006 | 59 | 0.280 |
Why?
| | Hepacivirus | 1 | 2006 | 230 | 0.250 |
Why?
| | Transplantation Immunology | 2 | 1999 | 31 | 0.250 |
Why?
| | Recombinant Fusion Proteins | 2 | 2006 | 650 | 0.240 |
Why?
| | Biological Assay | 1 | 2004 | 122 | 0.230 |
Why?
| | Adenoviridae | 3 | 2004 | 191 | 0.210 |
Why?
| | Graft Rejection | 3 | 2002 | 548 | 0.210 |
Why?
| | Tumor Cells, Cultured | 13 | 2003 | 871 | 0.190 |
Why?
| | Animals | 38 | 2012 | 33152 | 0.180 |
Why?
| | Prostatic Neoplasms | 4 | 1999 | 939 | 0.180 |
Why?
| | Testis | 2 | 1999 | 144 | 0.170 |
Why?
| | Mice | 27 | 2010 | 15446 | 0.160 |
Why?
| | Mice, Inbred BALB C | 8 | 2010 | 1202 | 0.150 |
Why?
| | Thymus Gland | 1 | 1999 | 298 | 0.150 |
Why?
| | Bacterial Toxins | 2 | 1996 | 105 | 0.150 |
Why?
| | Viral Proteins | 1 | 1999 | 290 | 0.140 |
Why?
| | DNA Damage | 2 | 1989 | 356 | 0.140 |
Why?
| | Endonucleases | 4 | 1988 | 31 | 0.140 |
Why?
| | DNA | 7 | 1994 | 1385 | 0.120 |
Why?
| | Melitten | 1 | 1994 | 3 | 0.120 |
Why?
| | Valinomycin | 1 | 1994 | 4 | 0.120 |
Why?
| | Calcimycin | 1 | 1994 | 57 | 0.120 |
Why?
| | Hemolysin Proteins | 1 | 1994 | 32 | 0.120 |
Why?
| | Dogs | 2 | 2012 | 369 | 0.110 |
Why?
| | Lymphocyte Activation | 6 | 2004 | 1062 | 0.110 |
Why?
| | Interleukin-2 | 5 | 1998 | 416 | 0.110 |
Why?
| | Transfection | 3 | 1999 | 887 | 0.110 |
Why?
| | Necrosis | 2 | 2012 | 230 | 0.110 |
Why?
| | Vaccines, Synthetic | 3 | 2010 | 125 | 0.100 |
Why?
| | Osteosarcoma | 1 | 2012 | 70 | 0.100 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 60 | 0.090 |
Why?
| | Melanoma | 3 | 2003 | 664 | 0.090 |
Why?
| | Calcium | 3 | 1994 | 1151 | 0.090 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 92 | 0.090 |
Why?
| | Cancer Vaccines | 1 | 2010 | 139 | 0.090 |
Why?
| | AIDS Vaccines | 2 | 2001 | 41 | 0.080 |
Why?
| | Major Histocompatibility Complex | 1 | 1989 | 220 | 0.080 |
Why?
| | Cytoplasmic Granules | 1 | 1988 | 83 | 0.080 |
Why?
| | Cell Line | 7 | 1998 | 2693 | 0.080 |
Why?
| | Neoplasms, Experimental | 2 | 2004 | 156 | 0.070 |
Why?
| | Ionomycin | 2 | 2004 | 24 | 0.070 |
Why?
| | Mice, Inbred C57BL | 6 | 2010 | 4887 | 0.070 |
Why?
| | Lymphocyte Depletion | 1 | 1986 | 116 | 0.070 |
Why?
| | Mice, Inbred Strains | 4 | 2004 | 404 | 0.070 |
Why?
| | Yeasts | 1 | 2005 | 52 | 0.060 |
Why?
| | Autoimmunity | 2 | 2004 | 831 | 0.060 |
Why?
| | HeLa Cells | 1 | 2006 | 583 | 0.060 |
Why?
| | Lymphocytes | 4 | 1998 | 346 | 0.060 |
Why?
| | Ionophores | 1 | 2004 | 25 | 0.060 |
Why?
| | Egtazic Acid | 1 | 2004 | 40 | 0.060 |
Why?
| | DNA Fragmentation | 1 | 2004 | 47 | 0.060 |
Why?
| | Hepatitis C | 1 | 2006 | 217 | 0.060 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2004 | 153 | 0.060 |
Why?
| | In Situ Nick-End Labeling | 1 | 2004 | 124 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2002 | 979 | 0.060 |
Why?
| | Chelating Agents | 1 | 2004 | 70 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2010 | 2855 | 0.060 |
Why?
| | Antigens, Neoplasm | 1 | 2005 | 228 | 0.060 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2004 | 237 | 0.060 |
Why?
| | Membrane Proteins | 1 | 1989 | 1048 | 0.060 |
Why?
| | Cell Survival | 4 | 1991 | 1045 | 0.060 |
Why?
| | Dog Diseases | 1 | 2003 | 43 | 0.060 |
Why?
| | Ultraviolet Rays | 2 | 2004 | 381 | 0.060 |
Why?
| | Cell Division | 3 | 2002 | 775 | 0.060 |
Why?
| | Microscopy | 1 | 2004 | 124 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2004 | 133 | 0.050 |
Why?
| | Glucocorticoids | 3 | 1999 | 545 | 0.050 |
Why?
| | Genes, ras | 1 | 2002 | 95 | 0.050 |
Why?
| | Cytokines | 3 | 2006 | 1880 | 0.050 |
Why?
| | Fluorescent Dyes | 1 | 2004 | 313 | 0.050 |
Why?
| | Immunity, Cellular | 2 | 2001 | 268 | 0.050 |
Why?
| | Perforin | 2 | 1992 | 19 | 0.050 |
Why?
| | Pore Forming Cytotoxic Proteins | 2 | 1992 | 16 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2002 | 412 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2004 | 1161 | 0.050 |
Why?
| | Flow Cytometry | 3 | 1999 | 1072 | 0.050 |
Why?
| | B-Lymphocytes | 2 | 1996 | 767 | 0.050 |
Why?
| | Humans | 22 | 2006 | 118270 | 0.050 |
Why?
| | DNA Primers | 3 | 1996 | 532 | 0.050 |
Why?
| | Antigens | 2 | 1992 | 319 | 0.050 |
Why?
| | HIV-1 | 2 | 1996 | 772 | 0.050 |
Why?
| | Lung Neoplasms | 3 | 2004 | 2216 | 0.050 |
Why?
| | Lymphoma | 3 | 1998 | 179 | 0.040 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 1999 | 14 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2002 | 403 | 0.040 |
Why?
| | Base Sequence | 4 | 1996 | 2148 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 2837 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1999 | 67 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 1999 | 54 | 0.040 |
Why?
| | Poxviridae | 1 | 1999 | 2 | 0.040 |
Why?
| | Cell Transplantation | 1 | 1999 | 38 | 0.040 |
Why?
| | Spheroids, Cellular | 1 | 1999 | 57 | 0.040 |
Why?
| | Serpins | 1 | 1999 | 25 | 0.040 |
Why?
| | I-kappa B Proteins | 1 | 1999 | 78 | 0.040 |
Why?
| | Myocarditis | 1 | 2000 | 94 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 1999 | 193 | 0.040 |
Why?
| | Mice, Nude | 2 | 1999 | 662 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 1999 | 116 | 0.040 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1999 | 145 | 0.040 |
Why?
| | Receptors, Virus | 1 | 1998 | 78 | 0.040 |
Why?
| | Male | 12 | 2004 | 57479 | 0.040 |
Why?
| | Depsipeptides | 1 | 1998 | 13 | 0.040 |
Why?
| | Cell Adhesion | 1 | 1999 | 435 | 0.040 |
Why?
| | Toxoplasma | 1 | 1998 | 34 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2001 | 442 | 0.040 |
Why?
| | Cell Nucleus | 3 | 1994 | 577 | 0.040 |
Why?
| | Immunoglobulin M | 2 | 1998 | 251 | 0.040 |
Why?
| | Neoplasms | 2 | 2005 | 2160 | 0.040 |
Why?
| | Cell Death | 2 | 2004 | 336 | 0.040 |
Why?
| | HIV Envelope Protein gp160 | 1 | 1996 | 7 | 0.040 |
Why?
| | Molecular Weight | 2 | 1989 | 340 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1996 | 196 | 0.040 |
Why?
| | Superantigens | 1 | 1996 | 68 | 0.040 |
Why?
| | Enterotoxins | 1 | 1996 | 86 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 1996 | 86 | 0.030 |
Why?
| | Tissue Transplantation | 1 | 1995 | 11 | 0.030 |
Why?
| | Sertoli Cells | 1 | 1995 | 25 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1996 | 105 | 0.030 |
Why?
| | Cell Cycle | 1 | 1998 | 547 | 0.030 |
Why?
| | Endodeoxyribonucleases | 2 | 1986 | 60 | 0.030 |
Why?
| | HIV Envelope Protein gp120 | 1 | 1995 | 57 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 1999 | 563 | 0.030 |
Why?
| | Macrophage Colony-Stimulating Factor | 1 | 1995 | 18 | 0.030 |
Why?
| | Rats | 2 | 1999 | 5339 | 0.030 |
Why?
| | Alopecia Areata | 1 | 1995 | 11 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2002 | 2657 | 0.030 |
Why?
| | NF-kappa B | 1 | 1999 | 664 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 219 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2002 | 762 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2001 | 817 | 0.030 |
Why?
| | Hair | 1 | 1995 | 68 | 0.030 |
Why?
| | Receptors, Complement | 1 | 1995 | 115 | 0.030 |
Why?
| | Virus Diseases | 1 | 1996 | 197 | 0.030 |
Why?
| | Cells, Cultured | 4 | 2001 | 4044 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 1995 | 174 | 0.030 |
Why?
| | Mitochondria | 1 | 1999 | 785 | 0.030 |
Why?
| | Heart Diseases | 1 | 1996 | 340 | 0.030 |
Why?
| | Immunization | 1 | 1995 | 412 | 0.030 |
Why?
| | Spleen | 1 | 1995 | 504 | 0.030 |
Why?
| | Recombinant Proteins | 3 | 2004 | 1302 | 0.030 |
Why?
| | Fetus | 1 | 1996 | 690 | 0.030 |
Why?
| | Peptides | 1 | 1998 | 879 | 0.030 |
Why?
| | Mice, Transgenic | 3 | 2002 | 2012 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 1998 | 807 | 0.030 |
Why?
| | Protein Biosynthesis | 2 | 1984 | 395 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 2004 | 172 | 0.020 |
Why?
| | Zinc | 2 | 1984 | 261 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2063 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | Skin | 1 | 1995 | 657 | 0.020 |
Why?
| | Cardiomegaly | 2 | 2002 | 167 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 33 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1082 | 0.020 |
Why?
| | Terminology as Topic | 1 | 1991 | 199 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1999 | 810 | 0.020 |
Why?
| | Dexamethasone | 2 | 1999 | 319 | 0.020 |
Why?
| | Lectins | 1 | 1989 | 49 | 0.020 |
Why?
| | Mast-Cell Sarcoma | 1 | 1988 | 4 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 1988 | 59 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 649 | 0.020 |
Why?
| | Kidney | 1 | 1995 | 1351 | 0.020 |
Why?
| | Oligosaccharides | 1 | 1988 | 47 | 0.020 |
Why?
| | Species Specificity | 1 | 1989 | 559 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 822 | 0.020 |
Why?
| | Cell Separation | 1 | 1988 | 293 | 0.020 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1991 | 634 | 0.020 |
Why?
| | Histocompatibility Antigens | 1 | 1988 | 102 | 0.020 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 1986 | 46 | 0.020 |
Why?
| | Magnesium | 2 | 1985 | 150 | 0.020 |
Why?
| | Promoter Regions, Genetic | 2 | 2002 | 1157 | 0.020 |
Why?
| | Models, Molecular | 1 | 2010 | 1434 | 0.020 |
Why?
| | Urethane | 1 | 2004 | 41 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1984 | 25 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2004 | 153 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 203 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1984 | 204 | 0.010 |
Why?
| | Antibodies | 2 | 1996 | 381 | 0.010 |
Why?
| | Polymerase Chain Reaction | 2 | 1996 | 1004 | 0.010 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2002 | 21 | 0.010 |
Why?
| | Adenoma | 1 | 2004 | 191 | 0.010 |
Why?
| | Corticosterone | 1 | 1984 | 253 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1988 | 610 | 0.010 |
Why?
| | HIV Infections | 1 | 1995 | 2454 | 0.010 |
Why?
| | Myosin Heavy Chains | 1 | 2002 | 192 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 980 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2003 | 504 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2002 | 362 | 0.010 |
Why?
| | Cell Size | 1 | 2000 | 83 | 0.010 |
Why?
| | Kinetics | 1 | 1983 | 1623 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 10 | 1 | 1999 | 3 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 1999 | 3 | 0.010 |
Why?
| | Down-Regulation | 1 | 2002 | 623 | 0.010 |
Why?
| | Metallothionein | 1 | 1999 | 24 | 0.010 |
Why?
| | Dual Specificity Phosphatase 1 | 1 | 1999 | 29 | 0.010 |
Why?
| | Protein Phosphatase 1 | 1 | 1999 | 32 | 0.010 |
Why?
| | Transcription, Genetic | 2 | 1996 | 1322 | 0.010 |
Why?
| | Phytohemagglutinins | 1 | 1999 | 27 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 135 | 0.010 |
Why?
| | Phagocytosis | 2 | 1992 | 360 | 0.010 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 1999 | 52 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 57 | 0.010 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 1999 | 70 | 0.010 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 1998 | 7 | 0.010 |
Why?
| | Hybridomas | 1 | 1999 | 233 | 0.010 |
Why?
| | Thymus Neoplasms | 1 | 1998 | 21 | 0.010 |
Why?
| | Membrane Potentials | 1 | 1999 | 253 | 0.010 |
Why?
| | Thymoma | 1 | 1998 | 31 | 0.010 |
Why?
| | CD3 Complex | 1 | 1998 | 93 | 0.010 |
Why?
| | Cycloheximide | 1 | 1998 | 55 | 0.010 |
Why?
| | Dactinomycin | 1 | 1998 | 24 | 0.010 |
Why?
| | Caspases | 1 | 1999 | 267 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2002 | 725 | 0.010 |
Why?
| | Androgens | 1 | 1999 | 167 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 288 | 0.010 |
Why?
| | Gamma Rays | 1 | 1998 | 52 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 1998 | 249 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1998 | 409 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1998 | 302 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2000 | 461 | 0.010 |
Why?
| | Myocardium | 1 | 2002 | 965 | 0.010 |
Why?
| | Proprotein Convertase 5 | 1 | 1996 | 1 | 0.010 |
Why?
| | Ligands | 1 | 1998 | 565 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 542 | 0.010 |
Why?
| | Models, Immunological | 1 | 1996 | 92 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1996 | 265 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1999 | 406 | 0.010 |
Why?
| | HIV Antibodies | 1 | 1995 | 49 | 0.010 |
Why?
| | Multigene Family | 1 | 1996 | 200 | 0.010 |
Why?
| | Exudates and Transudates | 1 | 1995 | 14 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1995 | 8 | 0.010 |
Why?
| | Peritoneum | 1 | 1995 | 36 | 0.010 |
Why?
| | Proto-Oncogenes | 1 | 1995 | 27 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1996 | 541 | 0.010 |
Why?
| | Signal Transduction | 2 | 1998 | 4688 | 0.010 |
Why?
| | Adult | 1 | 1996 | 31328 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 1995 | 124 | 0.010 |
Why?
| | Rabbits | 1 | 1996 | 779 | 0.010 |
Why?
| | Antibody Formation | 1 | 1996 | 275 | 0.010 |
Why?
| | Plasmids | 1 | 1995 | 355 | 0.010 |
Why?
| | Reference Values | 1 | 1996 | 770 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1998 | 1221 | 0.010 |
Why?
| | Mammals | 1 | 1996 | 253 | 0.010 |
Why?
| | Epidermis | 1 | 1995 | 152 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1482 | 0.010 |
Why?
| | Mutation | 1 | 2004 | 3435 | 0.010 |
Why?
| | Keratinocytes | 1 | 1995 | 227 | 0.010 |
Why?
| | Administration, Oral | 1 | 1995 | 753 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 2990 | 0.010 |
Why?
| | Interferon-gamma | 1 | 1996 | 735 | 0.010 |
Why?
| | Staphylococcus aureus | 1 | 1996 | 394 | 0.010 |
Why?
| | Immunity, Innate | 1 | 1998 | 744 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1343 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 1996 | 785 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1996 | 1937 | 0.010 |
Why?
| | Phenotype | 1 | 1999 | 2937 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 126 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1995 | 529 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 1998 | 1514 | 0.010 |
Why?
| | Clone Cells | 1 | 1988 | 247 | 0.000 |
Why?
| | Neoplasm Transplantation | 1 | 1988 | 245 | 0.000 |
Why?
| | Interphase | 1 | 1985 | 30 | 0.000 |
Why?
| | Female | 2 | 2004 | 61269 | 0.000 |
Why?
| | Antibodies, Monoclonal | 1 | 1988 | 1280 | 0.000 |
Why?
|
|
Duke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|